Bio-Techne (TECH) Net Cash Flow Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.04% |
| Dec 31, 2025 | 37.54% |
| Sep 30, 2025 | -21.96% |
| Jun 30, 2025 | 22.73% |
| Mar 31, 2025 | -21.99% |
| Dec 31, 2024 | -21.76% |
| Sep 30, 2024 | 91.64% |
| Jun 30, 2024 | 2.83% |
| Mar 31, 2024 | 9.00% |
| Dec 31, 2023 | -21.54% |
| Sep 30, 2023 | 2.34% |
| Jun 30, 2023 | 6.36% |
| Mar 31, 2023 | -1.30% |
| Dec 31, 2022 | -16.69% |
| Sep 30, 2022 | 17.56% |
| Jun 30, 2022 | -8.99% |
| Mar 31, 2022 | -148.69% |
| Dec 31, 2021 | 27.56% |
| Sep 30, 2021 | 24.09% |
| Jun 30, 2021 | 79.04% |
| Mar 31, 2021 | 40.46% |
| Dec 31, 2020 | -19.75% |
| Sep 30, 2020 | 31.96% |
| Jun 30, 2020 | 28.08% |
| Mar 31, 2020 | 25.15% |
| Dec 31, 2019 | 41.11% |
| Sep 30, 2019 | 14.93% |
| Jun 30, 2019 | -50.54% |
| Mar 31, 2019 | -20.58% |
| Dec 31, 2018 | -21.16% |
| Sep 30, 2018 | 20.53% |
| Jun 30, 2018 | 25.89% |
| Mar 31, 2018 | -40.94% |
| Dec 31, 2017 | 32.18% |
| Sep 30, 2017 | -28.34% |
| Jun 30, 2017 | 5.63% |
| Mar 31, 2017 | -48.12% |
| Dec 31, 2016 | -43.78% |
| Sep 30, 2016 | -25.58% |
| Jun 30, 2016 | 14.97% |
| Mar 31, 2016 | -28.79% |
| Dec 31, 2015 | -1.62% |
| Sep 30, 2015 | -21.59% |
| Jun 30, 2015 | -34.51% |
| Mar 31, 2015 | 17.22% |
| Dec 31, 2014 | -15.93% |
| Sep 30, 2014 | -72.05% |